A Novel Mutation in the OXCT1 Gene Causing Succinyl-CoA:3-Ketoacid CoA Transferase (SCOT) Deficiency Starting with Neurologic Manifestations
Iranian Journal of Child Neurology,
Vol. 17 No. 2 (2023),
16 March 2023
,
Page 127-133
https://doi.org/10.22037/ijcn.v17i2.35963
Abstract
Succinyl-CoA:3-oxoacid CoA-transferase (SCOT) deficiency is an inborn error of ketone body utilization characterized by intermittent ketoacidosis crises. This study reports the first Iranian patient with SCOT deficiency who presented with seizure and hypotonia at birth.
Accordingly, she was consequently re-hospitalized due to hypotonia and respiratory distress. Laboratory tests revealed hyperammonemia, ketonuria, and metabolic acidosis. Besides, the plasma glucose level was normal without any other abnormality. Despite treatment with high-dose bicarbonate, severe acidosis persisted. Poor response to treatment raised a significant diagnostic challenge among specialists until genetic investigation identified a homozygous nonsense mutation (c.79G>T; p.Gly27*) in the OXCT1 gene (NM_000436), causing SCOT deficiency. Genetic studies help clinicians achieve a definite diagnosis of such metabolic disorders. In this case, the accurate and early diagnosis of SCOT deficiency opened new therapeutic possibilities, including frequent carbohydrate-rich meals and low fat and protein diet. Moreover, our findings expand the mutational and clinical spectrum of SCOT deficiency.
- Succinyl-CoA:3-oxoacid CoA transferase deficiency; Iran; Next-generation sequencing (NGS), OXCT1 gene
How to Cite
References
2. Cotter DG, d'Avignon DA, Wentz AE, Weber ML, Crawford PA. Obligate role for ketone body oxidation in neonatal metabolic homeostasis. Journal of Biological Chemistry. 2011;286(9):6902-10.
3. Fukao T, Lopaschuk GD, Mitchell GA. Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prostaglandins, leukotrienes and essential fatty acids. 2004;70(3):243-51.
4. Grabacka M, Pierzchalska M, Dean M, Reiss K. Regulation of ketone body metabolism and the role of PPARα. International journal of molecular sciences. 2016;17(12):2093.
5. Puchalska P, Crawford PA. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell metabolism. 2017;25(2):262-84.
6. Crawford P. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Biophysical Journal. 2019;116(3):2a.
7. Berry G, Fukao T, Mitchell G, Mazur A, Ciafre M, Gibson J, et al. Neonatal hypoglycaemia in severe succinyl‐CoA: 3‐oxoacid CoA‐transferase deficiency. Journal of inherited metabolic disease. 2001;24(5):587-95.
8. Saudbray J, Specola N, Middleton B, Lombes A, Bonnefont J, Jakobs C, et al. Hyperketotic states due to inherited defects of ketolysis. Enzyme. 1987;38:80-90.
9. Fukao T, Shintaku H, Kusubae R, Zhang GX, Nakamura K, Kondo M, et al. Patients homozygous for the T435N mutation of succinyl-CoA: 3-ketoacid CoA Transferase (SCOT) do not show permanent ketosis. Pediatric research. 2004;56(6):858-63.
10. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in medicine. 2015;17(5):405-23.
11. Dixon MA, Leonard J. Intercurrent illness in inborn errors of intermediary metabolism. Archives of disease in childhood. 1992;67(11):1387-91.
12. Erdol S, Ture M, Yakut T, Saglam H, Sasai H, Abdelkreem E, et al. A Turkish patient with succinyl-CoA: 3-oxoacid CoA transferase deficiency mimicking diabetic ketoacidosis. Journal of Inborn Errors of Metabolism and Screening. 2019;4.
13. Fukao T, Sass JO, Kursula P, Thimm E, Wendel U, Ficicioglu C, et al. Clinical and molecular characterization of five patients with succinyl-CoA: 3-ketoacid CoA transferase (SCOT) deficiency. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2011;1812(5):619-24.
14. Mitchell G. Kassovska-Bratinova S, Boukaftane Y, Robert MF, Wang SP, Ashmarina L, Lambert M, Lapierre P, and Potier E. Medical aspects of ketone body metabolism Clin Invest Med. 1995;18:193-216.
15. Fukao T, Mitchell GA, Song X-Q, Nakamura H, Kassovska-Bratinova S, Orii KE, et al. Succinyl-CoA: 3-ketoacid CoA transferase (SCOT): cloning of the human SCOT gene, tertiary structural modeling of the human SCOT monomer, and characterization of three pathogenic mutations. Genomics. 2000;68(2):144-51.
16. Weinstein DA, Correia CE, Saunders AC, Wolfsdorf JI. Hepatic glycogen synthase deficiency: an infrequently recognized cause of ketotic hypoglycemia. Molecular genetics and metabolism. 2006;87(4):284-8.
- Abstract Viewed: 262 times